001     130723
005     20240228143456.0
024 7 _ |a 10.1158/0008-5472.CAN-16-0370
|2 doi
024 7 _ |a pmid:27216183
|2 pmid
024 7 _ |a 0008-5472
|2 ISSN
024 7 _ |a 0099-7013
|2 ISSN
024 7 _ |a 0099-7374
|2 ISSN
024 7 _ |a 1538-7445
|2 ISSN
024 7 _ |a altmetric:9837877
|2 altmetric
037 _ _ |a DKFZ-2017-05801
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Viarisio, Daniele
|0 P:(DE-He78)ebe4791a841be13f2939ae8dfa363c78
|b 0
|e Last author
|u dkfz
245 _ _ |a Novel ß-HPV49 Transgenic Mouse Model of Upper Digestive Tract Cancer.
260 _ _ |a Philadelphia, Pa.
|c 2016
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1525851262_16254
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The beta genus of human papillomaviruses (ß-HPV) includes approximately 50 different viral types that are subdivided into five species (ß-1 through ß-5). Nonmelanoma cancers may involve some ß-1 and ß-2 HPV types, but the biology of most ß-HPV types and their possible connections to human disease are still little characterized. In this study, we studied the effects of ß-3 type HPV49 in a novel transgenic (Tg) mouse model, using a cytokeratin K14 promoter to drive expression of the E6 and E7 genes from this virus in the basal skin epidermis and the mucosal epithelia of the digestive tract (K14 HPV49 E6/E7-Tg mice). Viral oncogene expression only marginally increased cellular proliferation in the epidermis of Tg animals, compared with wild-type littermates, and we observed no spontaneous tumor formation during their entire lifespan. However, we found that K14 HPV49 E6/E7-Tg mice were highly susceptible to upper digestive tract carcinogenesis upon initiation with 4-nitroquinoline 1-oxide (4NQO). This was a selective effect, as the same mice did not exhibit any skin lesions after chronic UV irradiation. Opposite results were observed in an analogous Tg model expressing the ß-2 HPV38 E6 and E7 oncogenes at the same anatomic sites. While these mice were highly susceptible to UV-induced skin carcinogenesis, as previously shown, they were little affected by 4NQO treatment. Overall, our findings highlight important differences in the biologic properties of certain ß-type HPV that affect their impact on carcinogenesis in an anatomic site-specific manner. Cancer Res; 76(14); 4216-25. ©2016 AACR.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Oncogene Proteins, Viral
|2 NLM Chemicals
650 _ 7 |a Papillomavirus E7 Proteins
|2 NLM Chemicals
700 1 _ |a Müller-Decker, Karin
|0 P:(DE-He78)799d978330dff449f8244947929a4518
|b 1
|u dkfz
700 1 _ |a Zanna, Paola
|b 2
700 1 _ |a Kloz, Ulrich
|0 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
|b 3
|u dkfz
700 1 _ |a Aengeneyndt, Birgit
|0 P:(DE-He78)84e026678d60a7fab7e35ca26289f15f
|b 4
|u dkfz
700 1 _ |a Accardi, Rosita
|b 5
700 1 _ |a Flechtenmacher, Christa
|b 6
700 1 _ |a Gissmann, Lutz
|0 P:(DE-He78)32e8be823590e784be4d5d488dd49538
|b 7
|u dkfz
700 1 _ |a Tommasino, Massimo
|b 8
773 _ _ |a 10.1158/0008-5472.CAN-16-0370
|g Vol. 76, no. 14, p. 4216 - 4225
|0 PERI:(DE-600)2036785-5
|n 14
|p 4216 - 4225
|t Cancer research
|v 76
|y 2016
|x 1538-7445
909 C O |o oai:inrepo02.dkfz.de:130723
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ebe4791a841be13f2939ae8dfa363c78
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)799d978330dff449f8244947929a4518
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)84e026678d60a7fab7e35ca26289f15f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)32e8be823590e784be4d5d488dd49538
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER RES : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER RES : 2015
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Molekulare Diagnostik Oncogener Infektionen
|x 0
920 1 _ |0 I:(DE-He78)W450-20160331
|k W450
|l Transgen-Service
|x 1
920 1 _ |0 I:(DE-He78)W420-20160331
|k W420
|l Tumormodelle
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a I:(DE-He78)W450-20160331
980 _ _ |a I:(DE-He78)W420-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21